4/A: NHI CIO Corrects Insider Award to 4,726 Shares
Insider Transaction Amendment
National Health Investors’ Chief Investment Officer Kevin Pascoe amended his Form 4 to correct a March 3, 2026 equity award to 4,726 shares, reducing a prior overstatement by 346 shares and confirming 73,082 shares held directly.
Summary
- Chief Investment Officer Kevin Carlton Pascoe reported an equity award of 4,726 shares of National Health Investors, Inc. (NHI) common stock on 03/03/2026 (transaction code A) at a price of $0.
- The previously reported number of awarded shares was overstated by 346 shares due to an administrative error; this amendment provides the correct figure.
- Following the correction, Pascoe beneficially owns 73,082 NHI shares directly.
- The original Form 4 was filed on 03/05/2026; the amended Form 4/A was signed on 03/30/2026 by attorney-in-fact Kimberly V. Ouimet.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as neutral: a minor administrative correction that improves disclosure accuracy without impacting fundamentals.
Positives
- Clarifies insider ownership with a corrected award of 4,726 shares, improving disclosure accuracy.
- Confirms total direct beneficial ownership of 73,082 shares for the CIO.
- Equity award reported at $0 aligns with customary restricted stock or grant practices, implying no market purchase.
Negatives
- Administrative error previously overstated the award by 346 shares, requiring an amendment.
Future Outlook
No forward-looking statements or guidance provided.
Management Comments
- Due to an administrative error, the number of securities reported as awarded on March 3, 2026 was overstated by 346 shares; this amendment reports the correct number of securities awarded.
- Signed by Kimberly V. Ouimet, by limited power of attorney, on 03/30/2026.
Industry Context
StockSavvy.ai notes that small, administrative Form 4/A corrections of insider awards are common across REITs and typically immaterial to valuation. Equity grants reported at $0 are consistent with standard restricted stock or grant practices in the REIT sector.
Comparison to Industry Standards
- Administrative Form 4/A corrections of minor share counts among REIT peers (e.g., Ventas, Welltower, Omega Healthcare Investors) are routine and historically non–market moving.
- Reporting insider equity awards at $0 is standard for issuer-granted restricted stock across listed REITs and aligns with common compensation structures.
- Absence of a Rule 10b5-1 trading plan designation is typical for grants (as opposed to open-market transactions), consistent with broader REIT practices.
Stakeholder Impact
- Adjusts previously reported insider holdings by 346 shares, confirming 73,082 shares held directly.
- No new derivative securities reported and no operational or strategic changes indicated.
Key Dates
| Date | Description |
|---|---|
| 03/03/2026 | Date of equity award (transaction code A) of 4,726 shares at $0 |
| 03/05/2026 | Date the original Form 4 was filed |
| 03/30/2026 | Date the Form 4/A amendment was signed by attorney-in-fact |
Keywords
National Health Investors, NHI, insider transaction, Form 4/A, Kevin Carlton Pascoe, Chief Investment Officer, restricted stock award, beneficial ownership, equity compensation, REIT
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.